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ABSTRACT 
Study objectives: This study examined empirically-derived symptom cluster proliles 
among patients who present with insomnia using clinical data and polysomnography 
(PSG). 
Methods: Latent profile analysis was used to identify symptom cluster profiles of 175 
individuals with insomnia disorder (ID; 63% female) based on total scores on validated 
self-report instruments of day- and night-time symptoms (Insomnia Severity Index, 
Glasgow Sleep Effort Scale, Fatigue Severity Scale, Beliefs and Attitudes about Sleep, 
Epworth Sleepiness Scale, Pre-Sleep Arousal Scale), mean values from a 7-day sleep diary 
(sleep onset latency [SOL], wake after sleep onset [WASO] and sleep efficiency [SE]), and 
total sleep time [TST] derived from a laboratory PSG.  
Results: The best fitting model had three symptom cluster profiles: “High Subjective 
Wakefulness” (HSW), “Mild Insomnia” (MI) and “Insomnia-Related Distress” (IRD). The 
HSW symptom cluster profile (26.3% of the sample) reported high WASO, high SOL, and 
low SE, and despite relatively comparable PSG-derived TST, reported greater levels of 
daytime sleepiness. The MI symptom cluster profile (45.1%) reported the least disturbance 
in the sleep diary and questionnaires and had the highest sleep efficiency. The IRD 
symptom cluster profile (28.6%) reported the highest mean scores on the insomnia-related 
distress measures (e.g., sleep effort and arousal) and waking correlates (fatigue). 
Covariates associated with symptom cluster membership were older age for the HSW 
profile, greater obstructive sleep apnoea (OSA) severity for the MI profile, and, when 
adjusting for OSA severity, being overweight/obese for the IRD profile.  
 Conclusion: The heterogeneous nature of insomnia disorder is captured by this data-
driven approach to identify symptom cluster profiles. The adaptation of a symptom cluster-
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based approach could guide tailored patient-centered management of patients presenting 
with insomnia, and enhance patient-care.  
Keywords: Insomnia Disorder, latent profile analysis, symptom profile, symptom clusters  
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INTRODUCTION 
Insomnia is the experience of the difficulty falling asleep, difficulty staying asleep, or early 
morning awakenings. About one-third to one-half of adults complains  of these symptoms.1 
Frequently, other complaints, such as sleepiness, fatigue, and hyperarousal, will occur with 
nocturnal sleep disturbance.  An insomnia disorder is defined in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM)-52 as the combination of the nocturnal sleep 
disturbance with one of these waking complaints at least 3 nights a week for at least 3 
months.  About 8-10% of the adult population meets these criteria.3,4  
 Insomnia disorder is a heterogeneous condition.5 This can pose a challenge for 
optimal patient care, because a ‘one size fits all’ approach does not provide treatment that 
is tailored to the patient’s unique combination of symptoms. The field of oncology has made 
great strides towards personalised/precision medicine6 by acknowledging the 
heterogeneity within the disease and matching treatment based on the individual’s 
symptom/genetic profiles. Many other areas have followed suit, and we believe that there 
is room for the same type of personalised medicine in insomnia and that this could greatly 
improve patient care. A management approach to insomnia disorder that is not confined to 
diagnostic boundaries and instead considers symptom cluster profiles, might offer a more 
targeted management by treating the most relevant symptoms. This would translate to 
assessment and treatment decisions informed by a profile based on the level of severity of 
each symptom. 
This hypothesis is based partly on results from our previous mixed-methods study,7 
which revealed that patients with multiple sleep symptoms tend to understand the 
symptoms and consequences better than diagnostic categories of sleep disorders. Yet, we 
as clinicians make decisions largely based on diagnostic categories.  Empirically deriving 
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symptom clusters for those who present with insomnia complaints might yield a model for 
a patient-centred approach.  There have been previous attempts to identify nighttime-and 
daytime symptom cluster profiles in patients with insomnia disorder using data-driven 
approaches.8-13 Similar attempts have been published characterising the heterogeneity of 
obstructive sleep apnoea.14,15  However, most of these studies used cluster analysis to 
characterise this  heterogeneity . In contrast, mixture models, such as latent class or profile 
analysis (LPA), have certain advantages over cluster analysis as described further in the 
statistical analysis section.   
 In general, the primary aim of LPA is to classify individuals into symptom profiles 
reflecting symptom clusters that consist of homogeneous individuals with regards to 
continuous observed variables being studied.18 While ensuring homogeneity within a 
symptom profile, the different profiles are distinct from each other and are viewed as 
representing the unobserved heterogeneity across individuals. Therefore, this person-
centered analytic technique uses actual empirical data, and not arbitrary dichotomization 
(such as diagnostic categories), to create quantitatively and qualitatively distinct profiles of 
individuals based on their dimensional presentation of day- and night-time symptoms of 
insomnia. Another strength of the analyses is the ability to examine covariates of symptom 
cluster membership. These may be tested in association with distinct outcome variables, 
such as treatment response, relapse risk or obstructive sleep apnea (OSA) risk, in future 
reports.  
To our knowledge, only two studies have used mixture models, such as latent profile 
or class analysis, to identify symptom cluster profiles within insomnia.16,17 Those studies, 
however, did not explore symptom profiles among patients who met criteria for an 
insomnia disorder. 16,17 The purpose of this study was to examine whether distinct 
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symptom profiles could be identified across a heterogeneous sample of insomnia patients 
who are representative of those presenting to a sleep clinic, including those with 
comorbidities such as Periodic Limb Movement Disorder (PLMD) or OSA. We hypothesised 
that distinct symptom cluster profiles would emerge. We believe that empirically derived 
symptom profiles can provide an impetus for a dimensional profile of sleep health,19 which 
might be useful for reducing the gap between patient understanding and clinical decision 
making based on categories.    
 
METHODS 
Study Sample 
 
Baseline assessments from two independent projects were used for this analysis. 
Individuals underwent a structured interview for sleep disorders20 and had to meet 
quantitative criteria for insomnia21 as determined by a 7-day sleep diary. Eligible 
participants had to be psychologically and medically stable, as evaluated by a structured 
interview for clinical disorders (SCID22) and medical exam by a physician (study 2 only) 
respectively. Lastly, individuals who were not fluent in English were excluded. Individuals 
who were taking sedative-hypnotic medications were only eligible if they stopped the 
medication under supervision of their prescribing physician.  
 There were minor differences in the inclusion criteria for both studies: study 1 
targeted individuals over 21 years of age with psychophysiological insomnia23, and study 2 
targeted individuals over 18 years of age with insomnia disorder and comorbid OSA24. For 
study 1, insomnia had to be present for at least 6 months to meet criteria for chronicity,25 
whereas for study 2 insomnia had to be present for at least 3 months (ICSD-326 and DSM-5 
criteria2). For study 2, unless agreeing not to drive, individuals who were excessively 
Running head: Profile analysis of patients with insomnia 
7 
sleepy were also excluded. Excessive sleepiness was defined by scores on the Epworth 
Sleepiness Scale27 score >16 or a score of 3 (high chance) on the ESS question about risk of 
dozing “In a car, while stopped for a few minutes in traffic” or a report of falling asleep at 
the wheel, an MVA, or near-miss accident due to sleepiness in the past 24 months, which in 
the judgment of the study physician was not attributable to acute sleep loss. All 
participants also had to be naïve to CPAP and CBT-I.  
By merging data from these two studies collected at the last step of the screening 
process (in –lab polysomnography, see below) we were able to capitalise on the 
homogeneity with regards to inclusion criteria (i.e., both studies included individuals with 
insomnia disorder) while retaining some heterogeneity with regards to exclusion criteria 
(i.e., in this analysis we included those who were excluded in both studies i.e.,  individuals 
with comorbid OSA [in study 1] and comorbid periodic limb movement [study 1 and 2]).   
 
Procedures  
The standard baseline assessment for both studies was designed to mimic common clinic 
procedures for new patients’ evaluations at a sleep clinic.  The baseline assessment 
consisted of a brief phone screen, an in-person interview, and an in-lab polysomnograph 
(PSG).  All individuals provided written informed consent. The institutional review board at 
Rush University Medical Center approved both studies. Data from participants who had 
successfully completed the baseline assessment were merged into one dataset. 
 
Measures  
At baseline, individuals completed a range of self-report questionnaires, a 7-day sleep 
diary, and a screening PSG.  
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Insomnia Severity Index (ISI).28 The ISI is a brief 7-item scale assessing nocturnal and 
daytime symptoms of insomnia, which has been used as both a screening and outcome 
measure in treatment research.  Total scores range from 0-28, with higher scores indicative 
of increase insomnia severity. The ISI has adequate internal consistency with evidence 
supporting concurrent, predictive, and content validity.29,30     
Glasgow Sleep Effort Scale (GSES).31 The GSES measures sleep-related effort as experienced 
in the past week. The seven items are reverse coded so that a higher score (range 0-14) 
indicates increased sleep effort (e.g., “I feel I should be able to control my sleep at night”). 
Adequate reliability and validity of this measure has been established.30  
Beliefs and Attitudes about Sleep Scale (BAS).32 The BAS is a 30-item measure of sleep-
related dysfunctional thinking. Individuals are asked to indicate the level of agreement on 
statements related to sleep; a strong endorsement of these statements is suggestive of 
dysfunctional beliefs and attitudes about sleep. The total scores were computed by 
summing all items, thus scores ranged from 0-300. The short-form version has acceptable 
internal consistency (Cronbach’s alpha between 0.8 and 0.8) and adequate test-retest 
reliability across a 2-week interval (r= .8).33 
Pre-Sleep Arousal Scale (PSAS).34 The PSAS is a 16-item questionnaire that assesses both 
cognitive and somatic arousal typically experienced during the sleep onset period. The total 
score ranges from 16-80 with a higher score reflective of increased arousal at bedtime.  
Fatigue Severity Scale (FSS).35 The FSS is a 9-item measure providing a global score of the 
intensity of an individual’s fatigue and has good internal consistency (α = 0.8-0.934). Scores 
range from 9-63 with increased scores reflective of increased fatigue. 
Epworth Sleepiness Scale (ESS).27 The ESS is a brief 8-item questionnaire measuring the 
propensity for drowsiness or falling asleep in eight common situations and correlates 
Running head: Profile analysis of patients with insomnia 
9 
moderately with sleep latency at night and during daytime naps.27 Total scores range from 
0-24 with higher scores indicating increased subjective sleepiness. 
Sleep diary. Prospective sleep diaries were completed daily across a 7-day period.  The 
following variables were derived for analyses and were included in the analytic model (see 
statistical analysis): sleep onset latency (SOL), wake after sleep onset (WASO) and sleep 
efficiency (SE, computed as the percent of time asleep relative to the time in bed). Study 1 
used an in-house sleep diary that is similar to the consensus sleep diary, but did not 
separate WASO from early morning awakenings (EMA); study 2 used the consensus core 
sleep diary.36 For study 2, EMA was added to WASO, so that this measure was comparable 
to study 1. 
Polysomnography (PSG). Each participant completed a technician-monitored, in-laboratory 
PSG to collect objective measures of sleep and respiratory events. Each study was scored by 
a registered polysomnography technologist and reviewed by a board-certified sleep 
medicine physician in accordance with the AASM Manual for the Scoring of Sleep and 
Associated Events.37 For our analyses the following variables were extracted: total sleep 
time [PSG-measured total sleep time (TST)], and Apnoea-Hypopnea Index (AHI). 
 
Statistical Analysis 
Preliminary statistical analyses included descriptive statistics and assessment of normality 
of distributions. Data for continuous variables are presented as means and standard 
deviations and were compared between profiles using independent t-tests. Categorical 
variables are presented as percentages and were compared with the chi-squared test. The 
Statistical Package for the Social Sciences (SPSS) version 19.0 was used for all preliminary 
analyses.  
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 Latent Profile analysis (LPA) was used to characterise insomnia symptom profiles. 
LPA is an empirically driven approach, which uses continuous variables (or indicators) to 
derive latent clusters of individuals with a particular symptom profile. Symptom cluster 
membership is inferred by examining the patterns of interrelationships among individuals 
with the goal of maximizing homogeneity within class (or symptom cluster profile) and 
heterogeneity between classes. Therefore, underlying this method is an emphasis on 
differentiating individuals (individual-based approach) based on scores on various 
indicators, rather than on one particular variable (variable-based approach). The following 
continuous indicators were used to characterise insomnia symptom profiles: total scores 
on the 1) ISI, 2) GSES, 3) FSS, 4) BAS, 5) ESS, and 6) PSAS, as well as mean self-reported 7) 
SOL, 8) WASO, and 9) sleep efficiency from a 7-day sleep diary and 10) PSG-measured TST. 
We used PSG- (rather than diary-) derived TST because of mounting evidence that 
insomnia with objective short sleep may form a distinct subtype of insomnia.10,38-42 The 
optimal number of  symptom cluster profiles was determined after examination of the 
following fit indices: the Akaike information criteria (AIC), the Bayesian information 
criteria (BIC), the sample-size adjusted BIC (ABIC), log-likelihood (LL), entropy, the 
adjusted likelihood ratio test (ALRT), and the parametric bootstrapped likelihood ratio test 
(BLRT).43 
Important advantages of LPA over standard cluster techniques have been identified 
in the literature.43 These include, for example, the ability to simultaneously include varying 
scales data in the same model, formal statistical criteria for selecting best fitting models, 
and most relevant to this study: the ability to examine associations between covariates and 
emerging profiles. Given this advantage, analyses were conducted in a two-step manner. 
First, the continuous indicators listed above were included in the model to identify 
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insomnia symptom cluster profiles. Second, covariates of symptom profiles were added to 
the model to examine cross-sectional associations between relevant covariates and 
symptom cluster profiles, using multinomial logistic regression. The following variables 
were entered as covariates: age, gender, education, race, ethnicity, BMI and AHI. Odds 
ratios (OR) of belonging to a  symptom cluster with a specific symptom profile were 
estimated for each covariate. All tests were two-sided and α<0.05 was considered to be 
statistically significant. Mplus version 6.0 was used for all LPA analyses.  
 
 
RESULTS 
Descriptive Characteristics  
Our sample was comprised of 175 individuals (n=110 female). Approximately 52.60% of 
individuals in our study identified as Caucasian, whereas 34.9%, 5.8%, 1.2% and 1.2% of 
the sample were African American, Asian, American Indian and Native Hawaiian, 
respectively. In regards to ethnicity, 8.8% of the sample identified as Hispanic/Latino. 
Mean age and education were 48.8 (SD=13.5) and 15.9 (SD=3.1) years, respectively. Mean 
AHI was significantly higher among men (M=21.0, SD=24.3) when compared to women 
(M=11.8, SD=19.2). No other significant differences in study variables were found across 
gender. In regards to AHI categories, 25.1% of the sample had mild OSA (AHI ≥5 and <15), 
20.6% had moderate OSA (AHI ≥15 and <30) and 14.3% had severe OSA (AHI ≥30). 
Detailed descriptive characteristics of the study sample are presented in Table 1.  
 
Characterisation of Insomnia Symptom Profiles 
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Multiple LPA models were examined with the number of symptom profiles (or latent 
clusters) ranging from 1 to 6. Fit indexes for all models are presented in Table 2. The AIC, 
BIC, aBIC and LL values decreased as the number of classes increased, which suggests that 
a greater number of clusters fit the data progressively better. Similarly, the BLRT was 
significant across comparisons of progressively greater number of clusters. Entropy values 
for the 3- to 6-cluster solution ranged from 0.838 to 0.945, indicating good fit to the data 
across all clusters. The ALRT test, however, suggested that the three-cluster solution was 
the best fitting model as it was shown to perform significantly better than the 2-cluster 
solution (p=0.028).  Further, the ALRT indicated that the 4-cluster solution was not 
significantly better than the three-cluster solution (p=0.161). In fact, proportion of 
individuals belonging to each cluster pronouncedly decreased as the number of clusters 
increased, and the 4-cluster solution included one symptom cluster profile comprised of 
only 8 individuals (5% of total sample). After collectively accounting for model fit indexes, 
as well as the size of each cluster, the 3-cluster solution was selected as best representing 
the data.  
 Based on visual examination of the severity and presentation of symptoms within 
the different profiles and discussion amongst the authors (MRC, DAC, JCO), the three latent 
symptom profiles were labeled the “High Subjective Wakefulness”, “Mild Insomnia”, and 
“Insomnia-related Distress”. The “Mild Insomnia” symptom cluster profile was the largest 
comprising 79 (45.1%) individuals, followed by the “Insomnia-related Distress” and the 
“High Subjective Wakefulness” symptom cluster profile with 50 (28.6%) and 46 (26.3%) 
individuals, respectively.  
Means and standard deviation of all indicators (self-report scales, 7-day sleep diary 
variables, and PSG TST) across each symptom cluster profile are presented in Table 3. As 
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shown in Figure 1 and 2 —the graphical representations of the 3 symptom profiles— the 
“High Subjective Wakefulness”  symptom cluster profile had the highest levels of daytime 
sleepiness (M=10.2; Z-score=0.5), and WASO, lasting on average 144 minutes, (Z-
score=1.3), high SOL (M=36.0, Z-score=0.5), and the lowest sleep efficiency (56.3%; Z-
score=-1.3) in spite of a relatively comparable objective total sleep time to the other two 
profiles (M=364.8, Z-score=-0.2). In contrast, the “Mild Insomnia”  symptom cluster profile 
presented with relative low means across most self-report and sleep diary variables and 
the highest diary-based sleep efficiency of all three  symptom cluster profiles (M=83.3%; Z-
score:0.6). Finally, the “Insomnia-related Distress”  symptom cluster profile was 
characterised by the highest overall means on self-report instruments measuring sleep 
arousal (PSAS M=40.4; Z-score=0.7), effort (GSES M=9.5; Z-score= 0.8) and symptomatic 
severity (ISI M=20.9; Z-score=0.7), as well as cognitions about sleep (BAS M=156.86, Z-
score=0.86) and daytime fatigue (FSS M=44.4; Z-score=0.7).  
 
 
Symptom Cluster Membership Covariates 
The inclusion of covariates to the model (age, gender, education, race, ethnicity, AHI 
category and BMI category) did not significantly alter the indicator mean scores for each 
symptom cluster profile, which further confirms the stability of the 3-cluster solution. 
Unadjusted mean values and percentages for each predictor by the three insomnia 
symptom cluster profiles are presented in Table 3. 
Participants across all insomnia symptom cluster profiles were comparable in terms 
of gender, education, race and ethnicity. However, significant predictors of  symptom 
cluster membership included age, OSA severity, and BMI category (see Table 4 for 
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unstandardized odds ratios for all variables). In terms of age, older participants were 
significantly more likely to belong to the “High Subjective Wakefulness” profile than the 
“Insomnia-related Distress” profile (OR=1.052, p=0.025) or the “Mild Insomnia” profile 
(OR=1.046, p=0.019). This indicates that for every one year increase in age participants 
were 5% more likely to belong to the “High Subjective Wakefulness” profile when 
compared to the “Insomnia-related Distress” or “Mild Insomnia” profile. No significant 
differences in age were found between the “Mild Insomnia” and “Insomnia-related 
Distress” profiles. In regards to AHI, participants with higher degree of OSA severity were 
significantly more likely to belong to the “Mild Insomnia” profile when compared to the 
“Insomnia-related Distress” (OR=1.870, p=0.018) or the “High Subjective Wakefulness” 
(OR=1.639, p=0.047) profiles. In fact, for every progressive increase in OSA severity 
category (no OSA vs. mild vs. moderate vs. severe), there was an 87% increase in the odds 
of belonging to the “Mild Insomnia” as compared to the “Insomnia-related Distress”profile. 
Similarly, for every progressive increase in OSA severity category, there was a 64% 
increase in participant’s odds of belonging to the “Mild Insomnia” profile as compared to 
the “High Subjective Wakefulness” profile. Finally, when adjusting for OSA severity, 
participants with greater degree of obesity were more likely to belong to the “Insomnia-
related Distress” than the “Mild Insomnia” (OR=1.804, p=0.008) profile. This indicates that 
overweight/obese participants had an 80% increase in their odds to belong to the 
“Insomnia-related Distress” profile when compared to the “Mild Insomnia” profile. No 
significant differences in BMI category were found between the “High Subjective 
Wakefulness” profiles and the other two symptom cluster profiles. 
  
DISCUSSION 
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Considering the heterogeneity of insomnia disorder, a symptom-based approach is a timely 
consideration. The aim of our study was to generate symptom cluster profiles, which could 
guide development of models of patient-centered care. A symptom cluster-based approach 
might provide a more personalised, precise management of the patient’s primary 
complaints. Unique patterns nested within the symptom cluster would otherwise be lost.59 
To do this, we used a different data-driven approach (latent profile analysis, LPA) in a 
sample of individuals who represent patients presenting to a sleep clinic for insomnia 
symptoms.   
Compared to most previous studies, we used data-driven methods here to 
characterise the heterogeneity, rather pre-determined categories as used in other studies.  
For example, pre-determined categories have included insomnia disorder subtypes, such as 
psychophysiological, paradoxical, idiopathic insomnia, insomnia related to a mental 
disorder, wich have been associated with different disease characteristics,44-46 treatment 
perceptions46,47 and treatment responses.46,48  Nightly insomnia symptoms (sleep onset or 
sleep maintenance problems or early morning awakenings) have also been associated with 
different disease characteristics49-55 and treatment responses.56,57 More recently, the 
heterogeneity driven by objective total sleep time has garnered attention. A number of 
studies have highlighted differential outcomes associated with short vs. long objective 
sleep.38-42,58 In contrast to these top-down approaches, data-driven methods, such as 
cluster analysis, have been applied to this area and have revealed that daytime symptoms 
such as sleepiness, fatigue, mood and sleep hygiene practices,9 nighttime symptoms such as 
objective sleep parameters,10 night-to-night variability and longitudinal development of 
subjective sleep variables11,16 and dysfunctional beliefs about sleep12 uniquely fall together 
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in identifiable and meaningful clusters. Others have used both sleep and psychiatric 
history, and daytime and nighttime symptoms to identify symptom clusters.8  
To our knowledge, only two studies to date have used sophisticated mixture models 
to derive symptom cluster profiles in individuals with sleep disturbances 17 or from a 
population-based sample.16 Foley and colleagues identified four symptom clusters (“weekly 
sleep disturbance and distressed”, “transient sleep disturbances”, “early morning 
awakenings” and “comorbid & non-restorative sleep”). Also using latent class analysis, 
Green and colleagues derived four symptom profiles, “healthy with low reports of sleep 
problems”, “episodic reports of sleep problems”, “developing over the 20 years” and 
“chronic problems of both sleep onset and maintenance problems”. 16 Our latent profile 
analysis reported here, builds on these previous studies. The symptom cluster profiles that 
emerged in our study were characterised by the following symptoms:  increased self-
reported wakefulness (“High Subjective Wakefulness”), low reporting of insomnia 
symptoms (“Mild Insomnia”) and high distress about sleeplessness and its consequences, 
(“Insomnia-related Distress”). 
 
 
“High Subjective Wakefulness” symptom cluster profile 
The “High Subjective Wakefulness” symptom cluster profile was best characterised by the 
significant subjective sleep disruption as reported on sleep diary (high SOL & WASO and 
low SE). This symptom cluster profile has similarities with one of Foley et al.’s symptom 
profiles17: the “difficulty maintaining sleep” group also reported high rates of sleep 
maintenance problems.  Interestingly, PSG-derived total sleep time of the HSW symptom 
cluster profile did not vary greatly from the other two profiles (10-20 minute difference), 
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yet the HSW reported taking 30 minutes longer to fall asleep than those with the mild 
insomnia profile and 90 minutes more wakefulness in the middle of the night than the 
other two symptom cluster profiles, which suggest potential overestimation of subjective 
wakefulness in the HSW symptom cluster profile. It is noteworthy, however, that this study 
used one night of PSG to determine objective total sleep time, compared to an average 7-
day sleep diary, hence measurement bias reduces the ability to estimate true extent of the 
sleep misperception. In addition, the use of only one PSG night raises the potential 
influence of “first-night effects”. Future replications, ideally with multiple consecutive 
nights, are needed at this stage; however it is worth mentioning that recent evidence 
emerged indicating the validity of one PSG night in the classification of short vs. long 
objective total sleep time for individuals with insomnia.60    
The statistical method of latent profile analysis enabled us to examine predictors of 
symptom cluster membership. Because participants of older age were more likely to belong 
to the HSW symptom cluster profile than to the other two symptom cluster profiles, it is 
possible that the observed elevation in subjective wakefulness might be explained in part 
by age-related increase in WASO.61 The average objective total sleep time for this symptom 
cluster profile —just above 6 hrs.— was below the sample’s overall average, thus 
individuals with this symptom profile might benefit from therapeutic approaches that lead 
to rapid sleep consolidation, for example sleep restriction, stimulus control or sedative-
hypnotics. Whether some of these individuals present with similar characteristics and 
sequelae as the symptom cluster profile “insomnia with objective short sleep”10,38-40,42,58 
remains to be elucidated in future studies.  
 
“Mild Insomnia” symptom cluster profile 
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The Mild Insomnia symptom cluster profile had less severe insomnia, less fatigue, more 
consolidated sleep and the least sleep-interfering mental activity (dysfunctional beliefs, 
sleep-related effort and pre-sleep arousal) of all profiles. There are similarities between 
this symptom cluster profile and Sánchez-Ortuño and colleagues’ “low endorsement” 
symptom profile.12 Sánchez-Ortuño’s profile scored low on all subscales of the beliefs and 
attitudes about sleep scale, reported least number of nights with insomnia complaints and 
had the lowest insomnia severity score.  
The results in the current study indicated that this symptom profile had the highest 
percent of cases with OSA overall and per severity level among the three symptom profiles. 
This symptom cluster profile might represent individuals with comorbid OSA and 
insomnia, who may not identify insomnia as their chief complaint. In a previous study on 
OSA and comorbid insomnia, we found that a quarter of the sample (24.1%) identified OSA 
(rather than insomnia) as their primary complaint.7 This finding has important clinical 
implication and could improve the precision and cost-effectiveness of evaluations 
conducted at sleep disorders clinics.  Specifically, whereas PSG is not currently 
recommended for the routine assessment of insomnia,62 a patient presenting for the 
treatment of insomnia whose symptom profile fits the “Mild Insomnia” symptom cluster 
profile might benefit from a PSG to evaluate the possible presence of OSA. The danger of 
OSA going undetected among insomnia patients has been previously documented. Krakow 
and colleagues found that in patients endorsing insomnia but no sleep disordered 
breathing (SDB) symptoms, most nighttime awakenings actually followed respiratory 
events, unbeknownst to the patient,63 and 50% of the sample met criteria for OSA. Fung et 
al. found that nearly half of study participants with insomnia suffered from occult SDB (AHI 
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≥ 15), and the presence of excessive daytime sleepiness was the distinguishing factor 
between occult and non-existent SDB.64 In the primary care setting, insomnia was found to 
predict OSA irrespective of age.65 Cronlein and colleagues found that occult OSA was most 
likely to be found on PSG in older and overweight individuals with insomnia, alluding to the 
possible necessity for PSGs in these patients.66 men with insomnia who frequently reported 
dry mouths were likely to have occult sleep apnoea even after been screened for possible 
OSA.67 Our findings complement these studies by highlighting the risks of occult OSA in 
insomnia patients, and this might be particularly prominent in those with the “Mild 
Insomnia” symptom profile. For this profile, treatment of insomnia using brief behavioural 
therapy68-70 might suffice, and these patients might require concomitant treatment for both 
insomnia disorder and OSA. 
We did not include participants who were excluded prior to the PSG screening 
evaluation (e.g., those who had a high [study 1] or low risk [study 2] for OSA based on 
subjective symptoms such as snoring or witness apnoeas or based on medical 
examination). This selection method might have biased our results, as we are left with two 
distinct samples at two extremes of the continuum: insomnia + no OSA for study 1, and 
insomnia + OSA for study 2. This selection bias might lead to an overrepresentation of the 
mild insomnia profile. In contrast, our analysis did include participants who underwent a 
screening PSG, even if they were excluded post-PSG from each individual parent study, 
which increases the selection of insomnia patients with comorbidities to a greater extent 
that most previous studies have done. 
 
“Insomnia-related Distress” symptom cluster profile 
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Finally, the “Insomnia-related Distress” symptom cluster profile was characterised by the 
highest reports of sleep-interfering mental activity and of fatigue. This profile is very 
similar to previously reported clusters> Sánchez-Ortuño and colleagues’ “worried and 
symptom focused” and “worried and medication biased” clusters; Edinger and colleagues’ 
“bedtime arousal” cluster; and Foley et al’s “distressed” cluster.8 These clusters are all 
characterised by pre-sleep arousal, distress, worry or dysfunctional beliefs about sleep. 
Interestingly, in the current study, those belonging to the “Insomnia-related Distress” 
symptom cluster profile were more likely to have no or mild OSA. Thus PSG evaluation 
would not likely be indicated, unless other risk factors such as snoring or witness apnoeas 
have been reported. Particularly noteworthy are the high rates of fatigue in this cluster, 
despite relatively comparable levels of daytime sleepiness to the other profiles (see table 3 
and figure 1, 2); this dichotomy is not present in other symptom cluster profile.  The 
dissociation between fatigue and sleepiness ratings has been highlighted previously, with 
the former more frequently reported in insomnia.73,74 
Controlling for OSA severity, overweight/obese participants were more likely to 
belong to the “Insomnia-related Distress” than the “Mild Insomnia” symptom cluster 
profile. Our findings report on cross-sectional data, thus preclude inference about causal 
relationships between insomnia-related distress and obesity; however these results might 
suggest avenues for further investigation.  Others have reported an association between 
obesity, insomnia and emotional stress,71 and psychological stress has been associated with 
changes in the production of appetite regulating hormones, such as ghrelin.72  
Patients who present with a symptom profile consistent with the “Insomnia-related 
Distress” symptom cluster profile might benefit from a treatment plan that includes 
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cognitive therapy, mindfulness or relaxation strategies to reduce the arousal, and distress 
and a mix of cognitive and behavioural components to address fatigue. 
One notable limitation that is relevant to this symptom profile is that parent study 1 
specifically recruited individuals with psychophysiological insomnia, thus individuals with 
heightened somatic and cognitive arousal at bedtime were overrepresented in this sample. 
This sample selection might have contributed to an overrepresentation of this symptom 
profile. 
 
Implications for clinical practice 
With our analysis we supplement previous data-driven attempts to characterise the 
symptoms cluster profiles within insomnia disorder. Symptom cluster profiles add 
important clinical data that may be lost when individuals are grouped within one single 
diagnostic boundary.  These symptom cluster profiles might also transcend diagnostic 
boundaries: in clinical practice, insomnia patients often share symptoms with other 
medical, psychiatric or sleep disorders, and so treatment decisions that are guided by 
symptom clusters, will not be biased by symptom overlap across comorbidities.   We hope 
that these results, along with other attempts, will inform clinical practice by guiding 
patient-centered care. We can see the success of these approaches in other areas such as 
oncology, 75 asthma,76 and various psychiatric disorders.77  The heterogeneity within 
insomnia disorder, lends itself to such an approach.  
We currently define insomnia disorder as a distinct entity, and our management of 
insomnia disorder is a one-size-fits-all approach, simply because we do not have sufficient 
evidence for a) valid and meaningful symptom cluster profiles, and b) whether treatments 
can be tailored to these symptom cluster profiles. The attempts to date, including ours and 
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future studies will help to move the needle towards a more patient-centred approach, 
which is gaining popularity in the US. With established and validated symptom clusters, we 
envision the practitioner can make assessment and treatment decisions based on the 
symptom cluster each individual patient reports. These findings are hopefully a catalyst for 
a dimensional profile of sleep health19 which might be useful for reducing the gap between 
patient experiences, and clinical decision making based on categories. A symptom profile 
based approach represents the middle ground on the dimension from very individualised 
medicine on the one side, and a one-size-fits-all approach on the other side. This approach 
would be more effective than the one-size-fits-all approach, because symptoms specific to 
the individual’s symptom profile are targeted, but more feasible in our current health 
system (particularly in the US) than an entirely individualised one, where time and cost 
limitations play a considerable role. We envision that established and validated symptom 
profiles will offer the practitioner with a model for patient-centered management of 
insomnia disorder.  
 
Summary  
Our results revealed three different symptom clusters in a group of individuals presenting 
with insomnia complaints, highlighting the symptom heterogeneity within insomnia 
disorder. Hopefully, these results provide an impetus for a symptom-based approach to the 
management of insomnia disorder. We intentionally selected self-reported variables for the 
profile analysis that have been recommended for the clinical evaluation of insomnia86 so 
that these results can easily translate to clinical practice. The vision is that the patient’s 
profile from these clinical measures could guide clinical decision-making when treating 
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insomnia. Undoubtedly though, before this approach can be translated into a model for 
interdisciplinary sleep clinics, further research is needed.  
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Table 1. Descriptive characteristics of the study sample  
    
Total Sample 
(n=175) Men (n=65) 
Women 
(n=110) 
p-value 
    Mean (SD)/% 
Mean 
(SD)/% Mean (SD)/% 
Demographic     
 Age, years 48.8 (13.5) 46.6 (12.9) 50.1 (13.8) 0.106 
 Race, Caucasian 53.5 56.3 51.9 0.147 
 Education, years 15.9 (3.2) 15.4 (3.4) 16.2 (3.0) 0.101 
Biological     
 Body Mass Index, kg/m2 29.2 (8.8) 29.3 (8.3) 29.2 (9.1) 0.964 
 Apnoea Hypopnea Index,  15.2 (21.6) 21.0 (24.3) 11.8 (19.2) 0.007* 
Sleep Diary and PSG     
 
Sleep Onset Latency, 
minutes 43.3 (37.2) 40.6 (40.4) 44.9 (35.4) 0.461 
 
Wake After Sleep Onset, 
minutes 58.9 (51.0) 50.8 (44.2) 64.1 (54.0) 0.077 
 Awakenings, number 2.3 (1.6) 2.4 (1.9) 2.3 (1.5) 0.958 
 Total Time in Bed, minutes 463.3 (99.4) 468.8 (71.6) 460.1 (112.4) 0.582 
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 Total Sleep Time, minutes 343.4 (116.2) 355.5 (88.1) 336.5 (129.4) 0.302 
 Sleep Efficiency, % 74.4 (14.0) 75.7 (13.9) 73.7 (14.1) 0.377 
 
PSG Total Sleep Time, 
minutes 379.2 (62.0) 381.4 (66.1) 378. (59.8) 0.727 
Self-Report Instruments     
 Insomnia Severity Scale 17.4 (4.8) 16.9 (4.8) 17.7 (4.8) 0.304 
 Glasgow Sleep Effort Scale 7.0 (3.4) 6.8 (3.4) 7.1 (3.3) 0.563 
 Fatigue Severity Scale 35.1 (12.8) 34.1(13.) 35.7 (12.7) 0.440 
 
Beliefs and Attitudes about 
Sleep 123.5 (38.9) 120.8 (37.7) 125.2 (39.7) 0.491 
 Epworth Sleepiness Scale 9.4 (4.9) 9.5 (4.9) 9.4 (5.0) 0.919 
 
Pre-Sleep Arousal Scale 
(PSAS) 33.5 (10.2) 31.6 (9.6) 34.7 (10.4) 0.061 
 
*p<0.05; PSG= Polysomnography.  
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Table 2. Fit indexes for latent profile analysis 
No. of 
clusters 
No. of 
parameters AIC BIC aBIC LL 
Entro
py 
ALRT 
(p) 
BLRT 
(p) 
1 20 
14052.
602 
14115.
897 
14052.
563 
-
7006.3
01 - - - 
2 31 
13893.
546 
13991.
655 
13893.
487 
-
6915.7
73 0.891 0.003* <0.001 
3 42 
13765.
682 
13898.
603 
13765.
602 
-
6840.8
41 0.838 0.028* <0.001 
4 53 
13660.
647 
13828.
380 
13660.
546 
-
6777.3
23 0.945 0.161 <0.001 
5 64 
13599.
327 
13801.
873 
13599.
205 
-
6735.6
62 0.878 0.251 <0.001 
6 75 
13557.
234 
13794.
593 
13557.
091 
-
6703.6
17 0.889 0.550 <0.001 
 
AIC=Akaike information criterion; BIC=Bayesian information criterion; aBIC=Adjusted BIC; LL=log-likelihood; ALRT=Adjusted 
likelihood ratio test; BLRT= Bootstrapped likelihood ratio test, *p<0.05. 
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Table 3. Indicators and unadjusted predictors means by symptom cluster profile 
    
High Subjective 
Wakefulness  
Mild 
Insomnia  
Insomnia-related 
Distress  
    n=46 (26.3%) n=79 (45.1%) n=50 (28.6%) 
Indicators    
 Insomnia Severity Index 18.6 (4.8) 14.4 (6.8) 20.9 (6.1) 
 Glasgow Sleep Effort Scale 7.1 (3.5) 5.2 (5.5) 9.5 (3.8) 
 Fatigue Severity Scale 32.6 (13.2) 30.5 (17.4) 44.4 (14.3) 
 
Beliefs and Attitudes about 
Sleep 
113.9 (50.0) 106.4 (46.9) 156.9 (62.7) 
 Epworth Sleepiness Scale 10.2 (5.6) 8.5 (5.0) 10.0 (7.3) 
 Pre-sleep Arousal Scale 33.0 (10.5) 29.4 (10.4) 40.4 (19.4) 
 Sleep Onset Latency 63.0 (50.1) 26.0. (21.7) 51.8(60.5) 
 Wake After Sleep Onset 144.4 (56.3) 51.9 (32.4) 52.1 (40.5) 
 Sleep Efficiency 56.3 (12.3) 83.3 (9.2) 77.6 (16.4) 
 PSG Total Sleep Time 364.8 (73.9) 388.6 (54.9) 378.3 (74.9) 
     
Predictors     
 Age, years 53.9 (14.4) 47.8 (13.1) 45.7 (12.3) 
 Gender, %female 71.7 54.4 68.0 
 Race, %Caucasian 46.7 56.4 55.1 
 Education, years 16.1 (3.4) 15.8 (3.1) 16.0 (3.2) 
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 Ethnicity, Hispanic 4.5 6.4 16.3 
 
BMI Category, % Normal 
Weight 43.5 38.0 30.0 
    Overweight 23.9 26.6 36.0 
    Obese 32.6 35.4 34.0 
 OSA Severity, % No OSA 47.8 30.4 48.0 
    Mild 19.6 26.6 28.0 
    Moderate 19.6 25.3 14.0 
     Severe 13.0 17.7 10.0 
 
PSG=Polysomnography; BMI=Body mass index; OSA=Obstructive sleep apnoea; AHI=Apnoea hypopnea index.   
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Table 4. Unstandardized odds ratios for symptom cluster membership 
 
    
Mild Insomnia vs.  
High Subjective 
Wakefulness 
Mild Insomnia vs.  
Insomnia-related 
Distress 
High Subjective 
Wakefulness vs. 
Insomnia-related 
Distress 
    OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Covariates       
 Age 
0.956 (0.926-
0.986) 0.019* 
1.005 (0.977-
1.034) 0.763 
1.052 
(1.013-
1.092) 0.025* 
 Gender 
0.665 (0.310-
1.428) 0.38 
0.698 (0.316-
1.541) 0.455 
1.049 (0.447-
2.459) 0.927 
 Education 
0.981 (0.875-
1.101) 0.786 
0.948 (0.845-
1.064) 0.448 
0.967 (0.851-
1.097) 0.659 
 Race  
0.968 (0.763-
1.228) 0.82 
1.072 (0.843-
1.362) 0.636 
1.108 (0.839-
1.462) 0.545 
 Ethnicity 
1.138 (0.225-
5.749) 0.896 
0.351 (0.102-
1.206) 0.163 
0.309 (0.065-
1.471) 0.216 
 
AHI 
Category 
1.639 (1.088-
2.467) 0.047* 
1.869 
(1.209-
2.891) 0.018* 
1.141 (0.704-
1.848) 0.653 
  
BMI 
Category 
0.868 (0.586-
1.285) 0.552 
0.554 
(0.384-
0.801) 0.008* 
0.639 (0.421-
0.971) 0.078 
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OR=Odds Ratio; CI= Confidence Intervals; AHI=Apnoea Hypopnea Index; BMI=Body Mass Index, *p<0.05.  
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